|Bid||165.43 x 800|
|Ask||169.74 x 1000|
|Day's range||161.78 - 168.60|
|52-week range||151.02 - 274.29|
|Beta (5Y monthly)||0.81|
|PE ratio (TTM)||75.91|
|Earnings date||28 Feb 2023 - 06 Mar 2023|
|Forward dividend & yield||N/A (N/A)|
|1y target est||215.50|
Veeva Systems (NYSE: VEEV) today announced findings from the latest Veeva Pulse Field Trends Report, the largest global industry benchmark of its kind on healthcare professional HCP engagement. Asia Pacific data shows that HCP access is limited and the growth of omnichannel engagement, across digital channels is driven by reps building effective relationships through use of relevant content.
Veeva Systems (NYSE: VEEV) and DigitalOcean (NYSE: DOCN) are both flying under many investors' radar. Each has had a solid 2022, but their stocks haven't performed very well, with Veeva down 34% and DigitalOcean down 65% this year. Veeva Systems is a crossover between a healthcare company and a tech company.
Veeva Systems' (NYSE: VEEV) stock dipped 4% during after-hours trading on Dec. 1, following its latest earnings report. Its adjusted net income grew 16% to $183.2 million, or $1.13 per share, also topping analysts' estimates by $0.06. It established a first-mover advantage in this niche market, and it was serving more than 1,200 customers worldwide -- including Pfizer, Johnson & Johnson, and Moderna -- at the end of fiscal 2022 (which ended on Jan. 31).